ZHOU Zhi-jun;XING Yan-tao;LIANG Xiao-long;XIAO Long;ZENG Shuang-ying;LI Pu;DENG Kun;WANG Yue;YU Jian-hong;LI Tao-jing
;HU Yong;HAN Ren;LI Ce-sheng;Sinopharm Wuhan Plasma-derived Biotherapies Co.,Ltd.;Objective To screen five currently commercially available 2019-nCoV IgG antibody detection kits(A,B,C,D and E) by comparing the specificity,sensitivity and linear range,and establish and validate a quantitative detection method for material plasma of human COVID-19 immunoglobulin(pH 4)for intravenous injection. Methods The COVID-19 convalescent plasma with neutralizing antibody activity was used as the internal control standard and 2-fold serially diluted to seven dilutions(S1 ~ S7). According to the instructions of the kits from five manufacturers,the absorbances of S1 at the highest concentration were compared,while the linear ranges were compared by using a four-parameter fitting curve. A quantitative detection method was developed with three candidate kits and used for determination of partial representative negative and positive samples,and the correlation of results was evaluated. A kit was selected based on comprehensive consideration,with which the dilution of the internal control standard was assigned after serial dilution to fit the standard curve and establish a quantitative detection method. The established method was validated for linear range,accuracy and precision,and used for establishmetnt of a plasma screening mode. after verifying its linear range,accuracy and precision. Results The linear range of the internal control standard showed that six dilutions were detected by kit A,while the absorbance of S1 was 2. 8;five dilutions were detected by kit B,while the absorbance of S1 was 2. 4;five dilutions were detected by kit C,while the absorbance of S1 was 1. 4;three dilutions were detected by kit D,while the absorbance of S1 was 3. 3;however,five 5 dilutions were detected bu kit E,while the absorbance of S1 was 3. 3. By using kits A,B,and E with similar linear ranges,a quantitative detection method was established with the internal control standard,of which the R2 of the curve and the recovery rates of various dilutions met the relevant requirements. The representative negative samples tested by kit A showed high background and poor specificity. The correlations between the determination results by three kits and the neutralization test of the representative positive samples were more than 0. 9.Kit B was selected finally,by which the dilution of the internal control standard determiend with three batches for 4 times was assigned as 32,and the four-parameter fitting curve was linearly established,and the linear range of dilution was 1 ~16,with a R2 value of more than 0. 99,indicationg that the accuracy and precision were qualified. The plasma screening mode was establilshed as single test each sample,and the dilution of retest sample was determiend. Conclusion The kit from manufacturer B is optimized as a quantitative detection kit,which may be used for the material plasma screening of human COVID-19 immunoglobulin for intravenous injection after validation.
2021 11 v.34 [Abstract][OnlineView][Download 373K]